BOLD vs WBD · P/E 0.1, $24.6M cap vs rev $39.32B
Boundless Bio, Inc. Common Stock (BOLD) versus Warner Bros Discovery Inc (WBD) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Warner Bros Discovery Inc (WBD) is a entertainment company listed on NASDAQ.
BOLD does not have a complete income-statement cache yet.
Latest reported WBD revenue for 2024-12-31 was $39.32B. Net income was -$11.48B. Revenue was down 4.8% from 2023-12-31 to 2024-12-31. WBD currently screens at market cap $66.93B.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. WBD currently screens at market cap $66.93B.
Not investment advice. Open the BOLD and WBD stock pages for the full models.
Not investment advice.